Pentacel pediatric vaccine approved

Pentacel pediatric vaccine approved
Pentacel pediatric vaccine approved

The FDA has approved Pentacel (DTaP/IPV/Hib vaccine, from sanofi pasteur) for active immunization of children from 6 weeks through 4 years of age against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to Haemophilus influenzae type b. Pentacel is administered as a four-dose primary series that can reduce the total number of injections infants and children receive in their first two years of life.

For more information call (800) VACCINE or visit www.pentacel.com.